Cerviche, I still reckon the sleeper concern for
FDA could be AE. There has been very little
mention of the possible reduction in blood
platelet numbers. Also the link with Elmiron,
however tenuous, it may be. We shall soon
know.
PAR. SP, page-1129
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
25.0¢ |
Change
-0.005(1.96%) |
Mkt cap ! $87.44M | |||
| Open | High | Low | Value | Volume |
| 25.5¢ | 25.5¢ | 24.0¢ | $45.48K | 182.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 8935 | 25.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 25.5¢ | 29565 | 3 |
View Market Depth
| Last trade - 16.10pm 28/08/2024 (20 minute delay) ? |
| PAR (ASX) Chart |